
GC65965
MPT0E028
Also known as (E)-3-[1-(benzenesulfonyl)-2,3-dihydroindol-5-yl]-N-hydroxyprop-2-enamide
MPT0E028 is an orally active and selective HDAC inhibitor with IC50s of 53·0 nM, 106·2 nM, 29·5 nM for HDAC1, HDAC2 and HDAC6, respectively· MPT0E028 reduces the viability of B-cell lymphomas by inducing apoptosis and possesses potent direct Akt targeting ability and reduces Akt phosphorylation in B-cell lymphoma· MPT0E028 has good anticancer activity
ChemicalCAS1338320-94-7MW344.38FormulaC17H16N2O4S
- CAS number
- 1338320-94-7
- Molecular weight
- 344.38
- Formula
- C17H16N2O4S
- InChIKey
- MGTIFSBCGGAZDB-VQHVLOKHSA-N
- Catalogue number
- GC65965
- Brand
- GLPBIO
Computed properties PubChem CID 53464642 · XLogP 1.9 · TPSA 95.1 Ų · H-bond donors 2
- XLogP
- 1.9
- TPSA
- 95.1 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 24
SMILES C1CN(C2=C1C=C(C=C2)/C=C/C(=O)NO)S(=O)(=O)C3=CC=CC=C3
Computed descriptors from PubChem (CID 53464642), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il